14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CYTX ranks #18788 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cytori Therapeutics Inc Stock Forecast NASDAQ:CYTX

$0.93 (-5.47%)

Volume: 460k

Closed: Jan 21, 2022

Hollow Logo Score: -6.107

Cytori Therapeutics Inc Stock Forecast

$0.93 (-5.47%)

Volume: 460k

Closed: Jan 21, 2022

Score Hollow Logo -6.107

Cytori Therapeutics Inc Company Profile

3020 Callan Road

San Diego CA 92121



Cytori Therapeutics Inc


Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan, and other regions. In addition, the company provides StemSource devices, including a cryogenic freezer, measuring and monitoring equipment, and a database patient tracking system, as well as offers consulting, installation, and training services. Cytori Therapeutics, Inc. markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales reps, distributors, and partners worldwide. The company was founded in 1996 and is headquartered in San Diego, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE